Medicated Skin Care in the Netherlands
Euromonitor International's Medicated Skin Care in the Netherlands market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 35 | Publication date: May 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Acne treatments; Antiparasitics/lice (head and body) treatments; Antipruritics; Child-specific medicated skin care; Emollients/therapeutic moisturisers; Haemorrhoid treatments; Hair loss treatments; Lip care treatments; Medicated shampoos; Nappy (diaper) rash treatments; Topical allergy remedies/antihistamines; Topical antifungals; Topical germicidals/antiseptics; Vaginal antifungals
Table of contents
MEDICATED SKIN CARE IN THE NETHERLANDS : MARKET INSIGHT
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 1 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 2 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 3 Herbal vs Standard Medicated Skin Care 2003-2008
Table 4 Acne Treatments by Format: % Value Breakdown 2004-2008
Table 5 Medicated Skin Care Company Shares by Value 2004-2008
Table 6 Medicated Skin Care Brand Shares by Value 2005-2008
Table 7 Acne Treatments Brand Shares by Value 2005-2008
Table 8 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 9 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 10 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
LOCAL COMPANY PROFILES - NETHERLANDS
BIONAL PHARMA BV - OTC HEALTHCARE - NETHERLANDS
STRATEGIC DIRECTION
KEY FACTS
Summary 1 Bional Pharma BV: Key Facts
Summary 2 Bional Pharma BV: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 3 Bional Pharma BV: Competitive Position 2008
CARESSE COSMETICS BV - OTC HEALTHCARE - NETHERLANDS
STRATEGIC DIRECTION
KEY FACTS
Summary 4 Caresse Cosmetics BV: Key Facts
Summary 5 Caresse Cosmetics BV: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
DISTRIBUTIE CARE BV - OTC HEALTHCARE - NETHERLANDS
STRATEGIC DIRECTION
KEY FACTS
Summary 6 Distributie Care BV: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 7 Distributie Care BV: Competitive Position 2008
INGROMA BV - OTC HEALTHCARE - NETHERLANDS
STRATEGIC DIRECTION
Summary 8 Ingroma BV: Key Facts
Summary 9 Ingroma BV: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
VEMEDIA BV - OTC HEALTHCARE - NETHERLANDS
STRATEGIC DIRECTION
KEY FACTS
Summary 10 Vemedia BV: Key Facts
Summary 11 Vemedia BV: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 12 Vemedia BV: Competitive Position 2008
OTC HEALTHCARE IN THE NETHERLANDS
EXECUTIVE SUMMARY
Prevention and innovation trends drive demand in 2008
Moderate impact of more open distribution through supermarkets
Continuing concentration trend among larger manufacturers
Online sales gradually increasing
Dutch quest for prevention to drive future demand
KEY TRENDS AND DEVELOPMENTS
Lower economic expansion envisaged
Health and prevention trends strongly influence OTC healthcare performance
Increasing ageing population influenced by quest for longevity
Dutch consumers become more interested in fitness and sports
Legislative changes allow wider distribution
MARKET INDICATORS
Table 11 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 12 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 13 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 14 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 15 OTC Healthcare Company Shares by Value 2004-2008
Table 16 OTC Healthcare Brand Shares by Value 2005-2008
Table 17 Penetration of Private Label by Sector 2003-2008
Table 18 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 19 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 20 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 21 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Labelling and patient information
Advertising
Distribution
Vitamins & Dietary Supplements Registration and Classification
EU Legislation
Self-medication and Preventative Medicine
Generics
Switches
Summary 13 OTC Healthcare Switches 2005-2008
DEFINITIONS
Summary 14 Research Sources